Alternate Dosing of Cetuximab for Patients With Metastatic Colorectal Cancer

BACKGROUND: Many chemotherapeutic regimens used to treat colorectal cancer (CRC), including 5-fluorouracil plus leucovorin in combination with irinotecan (FOLFIRI) or oxaliplatin (FOLFOX), are administered on an every-other-week (q2w) dosing schedule. Chemotherapy in combination with a monoclonal an...

Full description

Saved in:
Bibliographic Details
Main Authors: Hubbard, Joleen M., Alberts, Steven R.
Format: Artigo
Language:Inglês
Published: International Society of Gastrointestinal Oncology 2013
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674463/
https://ncbi.nlm.nih.gov/pubmed/23745159
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items